Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

8.6%

3 terminated/withdrawn out of 35 trials

Success Rate

84.2%

-2.3% vs industry average

Late-Stage Pipeline

29%

10 trials in Phase 3/4

Results Transparency

50%

8 of 16 completed trials have results

Key Signals

6 recruiting8 with results

Enrollment Performance

Analytics

N/A

22(68.8%)

Phase 4

8(25.0%)

Phase 3

2(6.3%)

32Total

N/A(22)

Phase 4(8)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials

NCT05768763Not ApplicableCompleted

SEARCH SAPPHIRE Phase B

Role: collaborator

NCT04978272Phase 3Active Not Recruiting

Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)

Role: collaborator

NCT05862857Not ApplicableCompleted

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1)

Role: collaborator

NCT07298785Not ApplicableRecruiting

Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot Study

Role: collaborator

NCT06971367Not ApplicableRecruiting

IBIS Megastudy of Interventions to Encourage HIV Retesting

Role: collaborator

NCT06785103Not ApplicableTerminated

IBIS Megastudy- Pilot

Role: collaborator

NCT07246525Phase 4Not Yet Recruiting

Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission

Role: collaborator

NCT05950191Not ApplicableCompleted

LLIN Evaluation in Uganda Project (LLINEUP3)

Role: collaborator

NCT05609513Not ApplicableCompleted

Integration of Hypertension Management in HIV Care in Uganda

Role: lead

NCT07322068Phase 4Not Yet Recruiting

Perennial Malaria Chemoprevention in the Malaria Vaccine Era

Role: collaborator

NCT04336189Phase 3Completed

Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda

Role: collaborator

NCT06036238Not ApplicableRecruiting

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)

Role: collaborator

NCT06474364Phase 4Recruiting

HIV Prevention and Care Interventions for Youth in Uganda

Role: collaborator

NCT07012421Recruiting

Community Antibiotic Use, Susceptibility and ResisTance Among Patients With Urinary Tract Infections (CAST-UTI)

Role: collaborator

NCT04557176Not ApplicableActive Not Recruiting

TB Screening Improves Preventive Therapy Uptake

Role: collaborator

NCT05437939Active Not Recruiting

Adverse Outcomes Following Female Genital Fistula Repair

Role: collaborator

NCT03453840Phase 4Completed

Extended Duration Artemether-lumefantrine Treatment for Malaria in Children

Role: collaborator

NCT06347471Phase 4Recruiting

The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy

Role: lead

NCT06122142Not ApplicableWithdrawn

Spatial Repellents for Malaria Control

Role: collaborator

NCT05549726Phase 4Completed

SEARCH CAB LA Dynamic Choice HIV Prevention Study Extension

Role: collaborator